CUFinder

Fabio Ciceri

About Fabio Ciceri

Fabio Ciceri, With an exceptional h-index of 54 and a recent h-index of 28 (since 2020), a distinguished researcher at Università Vita-Salute San Raffaele, specializes in the field of Hematology.

His recent articles reflect a diverse array of research interests and contributions to the field:

MicroCLOTS pathophysiology in coronavirus disease 2019

Real-life use of high-dose anakinra in covid-19 patients treated with remdesivir

SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS

HLA-haploidentical transplantation with PTCY in AML patients with active disease at transplantation: Better survival with bm than with PBSC in patients> 55 years

Availability of HLA-allele-matched unrelated donors and registry size: estimation from haplotype frequency in the Italian population

Severely low testosterone in men with COVID-19: A case-control study

Inverse correlation between central hypogonadism and circulating IL-10 levels in males with severe COVID-19

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

Fabio Ciceri Information

University

Position

MD Hematology BMT Unit

Citations(all)

11998

Citations(since 2020)

3331

Cited By

10113

hIndex(all)

54

hIndex(since 2020)

28

i10Index(all)

107

i10Index(since 2020)

64

Email

University Profile Page

Google Scholar

Fabio Ciceri Skills & Research Interests

Hematology

Top articles of Fabio Ciceri

MicroCLOTS pathophysiology in coronavirus disease 2019

The Korean Journal of Internal Medicine

2023/7

Samuele Renzi
Samuele Renzi

H-Index: 0

Giovanni Landoni
Giovanni Landoni

H-Index: 57

Fabio Ciceri
Fabio Ciceri

H-Index: 29

Real-life use of high-dose anakinra in covid-19 patients treated with remdesivir

Topics in Antiviral Medicine

2022

SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS

HAEMATOLOGICA

2022

HLA-haploidentical transplantation with PTCY in AML patients with active disease at transplantation: Better survival with bm than with PBSC in patients> 55 years

BONE MARROW TRANSPLANTATION

2022

Availability of HLA-allele-matched unrelated donors and registry size: estimation from haplotype frequency in the Italian population

Human Immunology

2021/10/1

Severely low testosterone in men with COVID-19: A case-control study

European Urology

2021/6

Inverse correlation between central hypogonadism and circulating IL-10 levels in males with severe COVID-19

European Urology

2021/6

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19

Scientific Reports

2021/5/17

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun 12: 2670

Nature communications

2021/5/11

Fabio Ciceri
Fabio Ciceri

H-Index: 29

Lorenzo Piemonti
Lorenzo Piemonti

H-Index: 46

HEMATOPOIETIC STEM CELL TRANSPLANTATION ACTIVITY DURING COVID-19 PANDEMIA

Haematologica

2021

Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study (vol 76, pg e10, 2020)

Hypertension

2020/8

Fabio Ciceri
Fabio Ciceri

H-Index: 29

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)

Bone Marrow Transplantation

2020/11

The biological underpinnings of perinatal depressive symptoms: A multi-systems approach.

Journal of Affective Disorders

2020/9/1

CO0001 MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPER-INFLAMMATION

2020/6/1

Multifocal transient cortical brain lesions: a consistent MRI finding in neuro-COVID-19 patients (preprint)

2020

Antonella Castellano
Antonella Castellano

H-Index: 19

Massimo Filippi
Massimo Filippi

H-Index: 82

Fabio Ciceri
Fabio Ciceri

H-Index: 29

See List of Professors in Fabio Ciceri University(Università Vita-Salute San Raffaele)